Arrowhead Pharmaceuticals (ARWR) Other Accumulated Expenses (2012 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Other Accumulated Expenses of $6.02 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 18.3% from $7.38 million a year earlier and down 46.2% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Other Accumulated Expenses came in at $10.81 million.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 263.6% (FY2020 to FY2025).
- In prior fiscal years, Arrowhead Pharmaceuticals' Other Accumulated Expenses was $432,000 in FY2024 (-0.7%) and $435,000 in FY2023.
- The fiscal Q3 2026 figure stands as the lowest quarterly Other Accumulated Expenses since fiscal Q2 2025.
- According to Business Quant data, Other Accumulated Expenses for the three prior fiscal quarters was $11.21 million (Q2 2026), $10.68 million (Q1 2026) and $10.81 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.02 Mn |
| Mar 31, 2026 | 11.21 Mn |
| Dec 31, 2025 | 10.68 Mn |
| Sep 30, 2025 | 10.81 Mn |
| Jun 30, 2025 | 7.38 Mn |
| Mar 31, 2025 | 448,000.00 |
| Dec 31, 2024 | 440,000.00 |
| Sep 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 417,000.00 |
| Mar 31, 2024 | 573,000.00 |
| Dec 31, 2023 | 461,000.00 |
| Sep 30, 2023 | 435,000.00 |
| Mar 31, 2021 | 17,000.00 |
| Dec 31, 2020 | 17,000.00 |
| Sep 30, 2020 | 17,000.00 |
| Jun 30, 2020 | 17,262.00 |
| Mar 31, 2020 | 17,263.00 |
| Dec 31, 2019 | 16,561.00 |
| Sep 30, 2019 | 16,561.00 |
| Sep 30, 2018 | 46,407.00 |
API Access
Arrowhead Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();